SPTLC1 Variants Associated with ALS Produce Distinct Sphingolipid Signatures through Impaired Interaction with ORMDL Proteins

Scientists showed that ORMDL binding to the holoenzyme complex was impaired in cells expressing pathogenic SPTLC1-ALS alleles, resulting in increased sphingolipid synthesis and a distinct lipid signature.